Chunlizhengda

Chunli Medical (688236+01858.HK), established in 1998, is an A+H listed company specializing in the research and development, production, and marketing of artificial joint and spine products, as well as sports medicine products. The company holds 42 product registration certificates and is one of the enterprises with the most comprehensive range of certifications in the field of artificial joints in China, covering four major categories of joint products: hip, knee, shoulder, and elbow. Chunli Medical was one of the earliest companies in mainland China to obtain the BIOLOX delta fourth-generation full ceramic and semi-ceramic joint registration certificate, and it also was among the first in China to hold the BIOLOX OPTION ceramic head with taper sleeve registration certificate, breaking the monopoly of international brands in ceramic joints. Meanwhile, Chunli Medical successfully developed a unicompartmental knee joint product, including both fixed-platform and mobile-platform unicompartmental knees, filling a gap in the domestic joint market. Chunli’s products have been exported to 47 countries and regions worldwide. Over its 23 years of establishment, Chunli Medical has grown to employ over a thousand staff members, including post-doctorates, doctors, MBAs, masters, bachelor's degree holders, and professionals with more than 15 years of industry experience. The talent pool spans multiple disciplines, including mechanical design, materials, biomechanics, clinical medicine, and computer science, forming a multidisciplinary professional team. The company has been recognized as a National High-tech Enterprise, and it hosts the Beijing Artificial Joint Engineering Laboratory and the Beijing Enterprise Technology Center. It has undertaken projects supported by the National Natural Science Foundation of China, the China Postdoctoral Science Foundation, and various government research programs from the Beijing Municipal Science & Technology Commission, Development and Reform Commission, and Economic and Information Technology Commission. As a leader in standard artificial joints and customized joints produced in China, Chunli Medical has broken foreign monopolies and elevated the level of independent innovation in China’s joint sector. As a pioneer in the domestic joint industry, Chunli Medical will continue to "carry forward the essence of predecessors and develop masterpieces for humanity," adhering to the philosophy of "treating products as if they were for personal use, constantly innovating" in research, development, and production. The company designs prostheses tailored to the characteristics of Chinese people and provides high-quality products to global customers, aspiring to become a globally renowned orthopedic enterprise.